Clinical Trial Tracker

Ongoing and recent psychedelic clinical trials worldwide

Total Trials

906

Active

Page

10 / 19

Filter by Substance

Filter by Condition

Year From

Year To

Filter by Phase

Filter by Status

Showing 50 of 906 trials

Phase 2/3RCT

NCT05446623

Cardiac Index and General Anesthesia Without Opioid.

SponsorCentre Hospitalier de Montauban

Enrollment120 participants

Start Date2021-01-01

NCT05446623—View on ClinicalTrials.gov

Phase 2RCT

NCT04630964

The Effect of Psilocybin on MDD Symptom Severity and Synaptic Density

Psilocybin

Major Depressive Disorder

SponsorSection for Affective Disorders; Northern Stockholm Psychiatry

Enrollment35 participants

Start Date2021-01-01

NCT04630964—View on ClinicalTrials.gov

NARCT

NCT04707378

Navigated Repetitive Transcranial Magnetic Stimulation for Parkinson's Disease With Depression or Cognitive Impairment

Major Depressive Disorder

SponsorGuangdong Provincial People's Hospital

Enrollment42 participants

Start Date2020-12-30

NCT04707378—View on ClinicalTrials.gov

Phase 4RCT

NCT04321746

The Effect of Ketamine on Postoperative Cognitive Dysfunction.

Ketamine

SponsorAssiut University

Enrollment45 participants

Start Date2020-12-10

NCT04321746—View on ClinicalTrials.gov

Phase 2RCT

NCT04600089

Ketamine in Patients Undergoing TEVAR Procedures Receiving NCI

Ketamine

SponsorSam Tyagi

Enrollment30 participants

Start Date2020-12-08

NCT04600089—View on ClinicalTrials.gov

NARCT

NCT05190952

Dexamethasone & Ketamine as Adjuvants to Bupivacaine for Incisional Infiltration in Pediatric Abdominal Operations

Ketamine

SponsorAin Shams University

Enrollment150 participants

Start Date2020-12-05

NCT05190952—View on ClinicalTrials.gov

NARCT

NCT04657107

The Efficacy and Safety of S-ketamine in Elective Cesarean Section

Ketamine

Major Depressive DisorderTreatment-Resistant Depression

SponsorBeijing Obstetrics and Gynecology Hospital

Enrollment402 participants

Start Date2020-12-01

NCT04657107—View on ClinicalTrials.gov

NARCT

NCT04691076

Effect of Low-dose Esketamine Combined With Target-controlled Infusion of Propofol for Painless Gastrointestinal Endoscopy

Ketamine

SponsorTianjin Union Medical Center

Enrollment1000 participants

Start Date2020-12-01

NCT04691076—View on ClinicalTrials.gov

NARCT

NCT04857450

Anesthesia for Upper Endoscopy and Colonoscopy in Cardiac Patients With Acute Anemia

Ketamine

SponsorKing Saud University

Enrollment60 participants

Start Date2020-11-20

NCT04857450—View on ClinicalTrials.gov

Phase 3RCT

NCT04227704

Ketamine to Prevent PPD After Cesarean

Ketamine

Major Depressive Disorder

SponsorWashington University School of Medicine

Enrollment25 participants

Start Date2020-11-12

NCT04227704—View on ClinicalTrials.gov

Phase 4RCT

NCT04359017

Systemic Absorption of Lidocaine After Hematoma Block

KetamineNitrous Oxide

SponsorWashington University School of Medicine

Start Date2020-11-01

NCT04359017—View on ClinicalTrials.gov

NARCT

NCT04597268

Dexmedetomidine Versus Ketamine Versus Midazolam in Endoscopic Procedures

Ketamine

SponsorNational Cancer Institute, Egypt

Enrollment75 participants

Start Date2020-11-01

NCT04597268—View on ClinicalTrials.gov

Phase 2RCT

NCT04003948

Preliminary Efficacy and Safety of Ibogaine in the Treatment of Methadone Detoxification

Ibogaine

SponsorInternational Center for Ethnobotanical Education, Research, and Service

Enrollment20 participants

Start Date2020-10-28

NCT04003948—View on ClinicalTrials.gov

Phase 4Pilot

NCT04504175

Ketamine for Older Adults Pilot

Ketamine

Major Depressive DisorderTreatment-Resistant Depression

SponsorWashington University School of Medicine

Enrollment25 participants

Start Date2020-10-22

NCT04504175—View on ClinicalTrials.gov

Phase 1RCT

NCT04558294

Effect of Ketanserin After LSD Administration

LSD-25

SponsorUniversity Hospital, Basel, Switzerland

Enrollment24 participants

Start Date2020-10-16

NCT04558294—View on ClinicalTrials.gov

NARCT

NCT04436250

ESKETamine for FIBromyalgia Treatment

Ketamine

Chronic Pain

SponsorGrand Hôpital de Charleroi

Enrollment23 participants

Start Date2020-10-10

NCT04436250—View on ClinicalTrials.gov

Phase 1RCT

NCT04678050

Dexmedetomidine Compared to Ketofol for Sedation in Paediatrics

Generalized Anxiety Disorder

SponsorAin Shams University

Enrollment40 participants

Start Date2020-10-10

NCT04678050—View on ClinicalTrials.gov

Phase 4RCT

NCT04894864

Opioid Free Anesthesia-Analgesia Strategy and Surgical Stress in Elective Open Abdominal Aortic Aneurysm Repair

Ketamine

SponsorUniversity of Crete

Enrollment40 participants

Start Date2020-10-08

NCT04894864—View on ClinicalTrials.gov

NARCT

NCT04705948

Comparing the Effect of Ketamine and Magnesium Sulfate Gargling With Placebo on Post-operative Sore Throat

Ketamine

SponsorUniversity Tunis El Manar

Enrollment60 participants

Start Date2020-10-07

NCT04705948—View on ClinicalTrials.gov

NARCT

NCT04700592

A Comparison of Gabapentin and Ketamine in Acute and Chronic Pain After Inguinal Hernia Repair

Ketamine

Chronic Pain

SponsorUniversity Tunis El Manar

Enrollment60 participants

Start Date2020-10-02

NCT04700592—View on ClinicalTrials.gov

Observational

NCT04527757

Duration of Anaesthesia Induction in Paediatric Patients: Prospective Observational Trial

Nitrous Oxide

SponsorBrno University Hospital

Enrollment1000 participants

Start Date2020-10-01

NCT04527757—View on ClinicalTrials.gov

Observational

NCT04676204

Relationship Between Oral DMT Burden and Adherence in MS

DMT / Ayahuasca

SponsorMonash University

Enrollment323 participants

Start Date2020-09-25

NCT04676204—View on ClinicalTrials.gov

Phase 3RCT

NCT04476446

An Expanded Access Protocol for Esketamine Treatment in Participants With Treatment Resistant Depression (TRD) Who do Not Have Other Treatment Alternatives

Ketamine

Major Depressive DisorderTreatment-Resistant Depression

SponsorJanssen-Cilag, S.A.

Enrollment41 participants

Start Date2020-09-08

NCT04476446—View on ClinicalTrials.gov

NARCT

NCT03998813

Chronic Pain and Functional Prognosis After Total Knee Replacement: Continuous Locoregional Analgesia by Catheter to the Femoral Triangle Versus Tissue Infiltration as Part of an Improved Rehabilitation After Surgery Approach

Ketamine

Chronic Pain

SponsorCentre Hospitalier Departemental Vendee

Enrollment287 participants

Start Date2020-09-02

NCT03998813—View on ClinicalTrials.gov

Phase 2RCT

NCT04959253

Psilocybin in Depression Resistant to Standard Treatments

Psilocybin

Major Depressive Disorder

SponsorKing's College London

Enrollment60 participants

Start Date2020-09-01

NCT04959253—View on ClinicalTrials.gov

NARCT

NCT04101474

Role Of Ketamine in Treatment-Resistant Major Depressive Disorder And Its Effect on Suicidality

Ketamine

Major Depressive Disorder

SponsorAssiut University

Enrollment36 participants

Start Date2020-09-01

NCT04101474—View on ClinicalTrials.gov

Phase 1RCT

NCT04620109

Clinical Evaluation of Safety and Tolerability of KDR2-2 Eye Drops in Healthy Volunteers With Pharmacokinetic Assessment

SponsorGuangzhou HuiBoRui Biological Pharmaceutical Technology Co. Ltd

Enrollment62 participants

Start Date2020-08-26

NCT04620109—View on ClinicalTrials.gov

NARCT

NCT04796389

Music for Anxiety in Critically Ill Patients

SponsorErasmus Medical Center

Enrollment104 participants

Start Date2020-08-24

NCT04796389—View on ClinicalTrials.gov

Phase 3RCT

NCT04338321

A Long-term Comparison of Esketamine Nasal Spray Versus Quetiapine Extended Release, Both in Combination With a Selective Serotonin Reuptake Inhibitor/Serotonin-Norepinephrine Reuptake Inhibitor, in Participants With Treatment Resistant Major Depressive Disorder

Ketamine

Major Depressive Disorder

SponsorJanssen-Cilag International NV

Enrollment676 participants

Start Date2020-08-21

NCT04338321—View on ClinicalTrials.gov

Phase 1/2Open-Label

NCT04388774

Low-Dose Ketamine in Children With ADNP Syndrome

Ketamine

SponsorAlexander Kolevzon

Enrollment10 participants

Start Date2020-08-19

NCT04388774—View on ClinicalTrials.gov

NARCT

NCT04613869

The Effect of Esketamine on Patients Undergoing Tumor Surgery

Ketamine

Major Depressive Disorder

SponsorSecond Affiliated Hospital, School of Medicine, Zhejiang University

Enrollment282 participants

Start Date2020-08-15

NCT04613869—View on ClinicalTrials.gov

Phase 2RCT

NCT04739865

The Safety and Efficacy Of Psilocybin as an Adjunctive Therapy in Participants With Treatment Resistant Depression

Psilocybin

Major Depressive DisorderTreatment-Resistant Depression

SponsorCOMPASS Pathways

Enrollment19 participants

Start Date2020-08-10

NCT04739865—View on ClinicalTrials.gov

NARCT

NCT04473846

Propofol-fentanyl-ketamine (PFK) Combination Versus General Anesthesia Using Propofol and Fentanyl in Patients Undergoing Endoscopic Procedures.

Ketamine

SponsorUniversity of Jordan

Enrollment200 participants

Start Date2020-08-01

NCT04473846—View on ClinicalTrials.gov

NARCT

NCT04399070

The Effect of S-ketamine for Patients Undergoing Electroconvulsive Therapy (ECT)

Ketamine

Major Depressive Disorder

SponsorYan Qiu

Enrollment150 participants

Start Date2020-08-01

NCT04399070—View on ClinicalTrials.gov

Phase 4RCT

NCT04129086

Ketamine for Acute Pain Management After Trauma

Ketamine

Chronic Pain

SponsorThe University of Texas Health Science Center, Houston

Enrollment305 participants

Start Date2020-07-01

NCT04129086—View on ClinicalTrials.gov

Phase 4RCT

NCT04997967

Ketofol Versus Propofol in Urgent ERCP for Acute Cholangitis

Major Depressive Disorder

SponsorAssiut University

Enrollment100 participants

Start Date2020-07-01

NCT04997967—View on ClinicalTrials.gov

Observational

NCT05796232

Pharmacogenetics of Ketamine in Children

Ketamine

SponsorIRCCS Burlo Garofolo

Enrollment250 participants

Start Date2020-06-26

NCT05796232—View on ClinicalTrials.gov

Phase 2Open-Label

NCT04030169

Open Label Study of MDMA-assisted Psychotherapy for Treatment of PTSD With Optional fMRI Sub-Study

MDMA

Post-Traumatic Stress Disorder

SponsorMAPS Europe B.V.

Enrollment21 participants

Start Date2020-06-24

NCT04030169—View on ClinicalTrials.gov

Phase 4RCT

NCT04248205

Ketamine for Post-operative Analgesia in Hemorrhoidectomy

Ketamine

SponsorUniversity of Oklahoma

Enrollment100 participants

Start Date2020-06-15

NCT04248205—View on ClinicalTrials.gov

Observational

NCT05438693

Delayed Diagnosis of Multiple Sclerosis, Treatment Initiation and Non-adherence in Upper Egypt

DMT / Ayahuasca

Sponsordoaa mokhtar mahmoud

Enrollment80 participants

Start Date2020-06-01

NCT05438693—View on ClinicalTrials.gov

Phase 1RCT

NCT04227756

Comparative Acute Effects of LSD, Psilocybin and Mescaline

PsilocybinMescalineLSD-25

SponsorUniversity Hospital, Basel, Switzerland

Enrollment32 participants

Start Date2020-05-19

NCT04227756—View on ClinicalTrials.gov

Observational

NCT05141669

Impact of Fingolimod Adherence on Outcomes

SponsorNovartis Pharmaceuticals

Enrollment694 participants

Start Date2020-05-18

NCT05141669—View on ClinicalTrials.gov

Phase 4Open-Label

NCT04352621

Study to Assess the Effects of Intranasal Ketamine Along With rTMS for Patients With Treatment-resistant Major Depressive Disorder (TRD)

Ketamine

Major Depressive DisorderTreatment-Resistant Depression

SponsorUniversity of Cincinnati

Enrollment20 participants

Start Date2020-05-01

NCT04352621—View on ClinicalTrials.gov

Phase 2RCT

NCT04365985

Study of Immunomodulation Using Naltrexone and Ketamine for COVID-19

Ketamine

Alcohol Use DisorderOpioid Use Disorder

SponsorCorewell Health East

Enrollment70 participants

Start Date2020-04-29

NCT04365985—View on ClinicalTrials.gov

NARCT

NCT04294992

Granisteron Versus Ondansetron for Prophylaxis Against Post-Spinal Anesthesia Shivering: a Randomized Controlled Study

Ketamine

Major Depressive Disorder

SponsorKasr El Aini Hospital

Enrollment180 participants

Start Date2020-04-01

NCT04294992—View on ClinicalTrials.gov

Phase 4RCT

NCT05604794

A Retrospective Effectiveness Trial of Ketamine-Assisted Psychotherapy in Adult Patients Coping With Mental Health

Ketamine

Major Depressive DisorderPost-Traumatic Stress Disorder

SponsorField Trip Health

Enrollment1806 participants

Start Date2020-03-13

NCT05604794—View on ClinicalTrials.gov

Phase 2/3RCT

NCT04195256

Intranasal Dexmedetomidine Plus Ketamine for Procedural Sedation

Ketamine

SponsorNaveen Poonai

Enrollment400 participants

Start Date2020-03-11

NCT04195256—View on ClinicalTrials.gov

Observational

NCT04667936

Evaluation of Sedation in COVID-19 ARDS

SponsorGoethe University

Enrollment114 participants

Start Date2020-03-01

NCT04667936—View on ClinicalTrials.gov

NARCT

NCT04285255

Quality of Recovery Following Opioids Free Anaesthesia in Laparoscopic Sleeve Gastrectomy

SponsorAl Mashfa Medical Center

Enrollment103 participants

Start Date2020-03-01

NCT04285255—View on ClinicalTrials.gov

Phase 3Open-Label

NCT03911505

ZIP Study-OL Study of Safety, PK, Efficacy, PD, Immunogenicity of ATB200/AT2221 in Pediatrics Aged 0 to < 18 y.o. w/LOPD

SponsorAmicus Therapeutics

Enrollment21 participants

Start Date2020-02-13

NCT03911505—View on ClinicalTrials.gov

PreviousPage 10 of 19Next

Stay Updated

Clinical Trial Tracker

Cardiac Index and General Anesthesia Without Opioid.

The Effect of Psilocybin on MDD Symptom Severity and Synaptic Density

Navigated Repetitive Transcranial Magnetic Stimulation for Parkinson's Disease With Depression or Cognitive Impairment

The Effect of Ketamine on Postoperative Cognitive Dysfunction.

Ketamine in Patients Undergoing TEVAR Procedures Receiving NCI

Dexamethasone & Ketamine as Adjuvants to Bupivacaine for Incisional Infiltration in Pediatric Abdominal Operations

The Efficacy and Safety of S-ketamine in Elective Cesarean Section

Effect of Low-dose Esketamine Combined With Target-controlled Infusion of Propofol for Painless Gastrointestinal Endoscopy

Anesthesia for Upper Endoscopy and Colonoscopy in Cardiac Patients With Acute Anemia

Ketamine to Prevent PPD After Cesarean

Systemic Absorption of Lidocaine After Hematoma Block

Dexmedetomidine Versus Ketamine Versus Midazolam in Endoscopic Procedures

Preliminary Efficacy and Safety of Ibogaine in the Treatment of Methadone Detoxification

Ketamine for Older Adults Pilot

Effect of Ketanserin After LSD Administration

ESKETamine for FIBromyalgia Treatment

Dexmedetomidine Compared to Ketofol for Sedation in Paediatrics

Opioid Free Anesthesia-Analgesia Strategy and Surgical Stress in Elective Open Abdominal Aortic Aneurysm Repair

Comparing the Effect of Ketamine and Magnesium Sulfate Gargling With Placebo on Post-operative Sore Throat

A Comparison of Gabapentin and Ketamine in Acute and Chronic Pain After Inguinal Hernia Repair

Duration of Anaesthesia Induction in Paediatric Patients: Prospective Observational Trial

Relationship Between Oral DMT Burden and Adherence in MS

An Expanded Access Protocol for Esketamine Treatment in Participants With Treatment Resistant Depression (TRD) Who do Not Have Other Treatment Alternatives

Chronic Pain and Functional Prognosis After Total Knee Replacement: Continuous Locoregional Analgesia by Catheter to the Femoral Triangle Versus Tissue Infiltration as Part of an Improved Rehabilitation After Surgery Approach

Psilocybin in Depression Resistant to Standard Treatments

Role Of Ketamine in Treatment-Resistant Major Depressive Disorder And Its Effect on Suicidality

Clinical Evaluation of Safety and Tolerability of KDR2-2 Eye Drops in Healthy Volunteers With Pharmacokinetic Assessment

Music for Anxiety in Critically Ill Patients

A Long-term Comparison of Esketamine Nasal Spray Versus Quetiapine Extended Release, Both in Combination With a Selective Serotonin Reuptake Inhibitor/Serotonin-Norepinephrine Reuptake Inhibitor, in Participants With Treatment Resistant Major Depressive Disorder

Low-Dose Ketamine in Children With ADNP Syndrome

The Effect of Esketamine on Patients Undergoing Tumor Surgery

The Safety and Efficacy Of Psilocybin as an Adjunctive Therapy in Participants With Treatment Resistant Depression

Propofol-fentanyl-ketamine (PFK) Combination Versus General Anesthesia Using Propofol and Fentanyl in Patients Undergoing Endoscopic Procedures.

The Effect of S-ketamine for Patients Undergoing Electroconvulsive Therapy (ECT)

Ketamine for Acute Pain Management After Trauma

Ketofol Versus Propofol in Urgent ERCP for Acute Cholangitis

Pharmacogenetics of Ketamine in Children

Open Label Study of MDMA-assisted Psychotherapy for Treatment of PTSD With Optional fMRI Sub-Study

Ketamine for Post-operative Analgesia in Hemorrhoidectomy

Delayed Diagnosis of Multiple Sclerosis, Treatment Initiation and Non-adherence in Upper Egypt

Comparative Acute Effects of LSD, Psilocybin and Mescaline

Impact of Fingolimod Adherence on Outcomes

Study to Assess the Effects of Intranasal Ketamine Along With rTMS for Patients With Treatment-resistant Major Depressive Disorder (TRD)

Study of Immunomodulation Using Naltrexone and Ketamine for COVID-19

Granisteron Versus Ondansetron for Prophylaxis Against Post-Spinal Anesthesia Shivering: a Randomized Controlled Study

A Retrospective Effectiveness Trial of Ketamine-Assisted Psychotherapy in Adult Patients Coping With Mental Health

Intranasal Dexmedetomidine Plus Ketamine for Procedural Sedation

Evaluation of Sedation in COVID-19 ARDS

Quality of Recovery Following Opioids Free Anaesthesia in Laparoscopic Sleeve Gastrectomy

ZIP Study-OL Study of Safety, PK, Efficacy, PD, Immunogenicity of ATB200/AT2221 in Pediatrics Aged 0 to < 18 y.o. w/LOPD